DNLI Denali Therapeutics Inc. logo

DNLI Denali Therapeutics Inc.

Healthcare
$18.64-3.42%ClosedMarket Cap: $2.96B

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

4

Dispositions

2

Buy/Sell Ratio

2.00

Net Shares

+494,224

Shares Acquired

546,640

Shares Disposed

52,416

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue Apr 21Chin Peter Scottofficer: Chief Medical OfficerSell0$0.00204,402
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell63,800$20.170
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell44,750$20.330
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell43,000$22.310
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell40,650$21.260
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell35,100$24.810
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell32,900$27.630
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell14,250$80.030
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell13,000$47.270
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell10,250$33.740
Mon Apr 20Chin Peter Scottofficer: Chief Medical OfficerSell0$0.00170,612
Thu Jan 08Watts Ryan J.director, officer: President and CEOSell35,198$16.50296,833
Thu Jan 08Schuth Alexander O.officer: COFO and SecretarySell17,218$16.50282,828
Mon Jan 05Watts Ryan J.director, officer: President and CEOSell236,880$16.27236,880
Mon Jan 05Watts Ryan J.director, officer: President and CEOSell78,960$0.00332,031